{"id":"https://openalex.org/W2050416697","doi":"https://doi.org/10.1158/1535-7163.targ-09-b123","title":"Abstract B123: A phase I study of R1507, a human monoclonal antibody IGF-1R (insulin-like growth factor receptor) antagonist in patients with advanced solid tumors","display_name":"Abstract B123: A phase I study of R1507, a human monoclonal antibody IGF-1R (insulin-like growth factor receptor) antagonist in patients with advanced solid tumors","publication_year":2009,"publication_date":"2009-12-01","ids":{"openalex":"https://openalex.org/W2050416697","doi":"https://doi.org/10.1158/1535-7163.targ-09-b123","mag":"2050416697"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-09-b123","doi":"https://doi.org/10.1158/1535-7163.targ-09-b123","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-09-b123","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037169725","display_name":"Lia Gore","orcid":"https://orcid.org/0000-0002-2546-4616","observed_orcids":["https://orcid.org/0000-0002-2546-4616"]},"institutions":[{"id":"https://openalex.org/I4210096275","display_name":"Children's Hospital Colorado","ror":"https://ror.org/00mj9k629","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210096275"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lia Gore","raw_affiliation_strings":["1 The Children's Hospital Center for Cancer and Blood Disorders, Aurora, CO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 The Children's Hospital Center for Cancer and Blood Disorders, Aurora, CO;","institution_ids":["https://openalex.org/I4210096275"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054371540","display_name":"Joseph Aisner","orcid":"https://orcid.org/0000-0003-0662-7077","observed_orcids":["https://orcid.org/0000-0003-0662-7077"]},"institutions":[{"id":"https://openalex.org/I4390039325","display_name":"Rutgers Cancer Institute","ror":"https://ror.org/0060x3y55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4390039325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Aisner","raw_affiliation_strings":["2 The Cancer Institute of New Jersey, New Brunswick, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2 The Cancer Institute of New Jersey, New Brunswick, NJ;","institution_ids":["https://openalex.org/I4390039325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Razelle Kurzrock","raw_affiliation_strings":["3 M. D. Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3 M. D. Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040437806","display_name":"Cinara D. McCarthy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cinara D. McCarthy","raw_affiliation_strings":["4 Hoffmann-La Roche Inc., Nutley, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4 Hoffmann-La Roche Inc., Nutley, NJ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103934431","display_name":"Erica Winter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erica Winter","raw_affiliation_strings":["4 Hoffmann-La Roche Inc., Nutley, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4 Hoffmann-La Roche Inc., Nutley, NJ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112793737","display_name":"Joseph F. Grippo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph Grippo","raw_affiliation_strings":["4 Hoffmann-La Roche Inc., Nutley, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4 Hoffmann-La Roche Inc., Nutley, NJ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110122469","display_name":"Stanley Frankel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stanley Frankel","raw_affiliation_strings":["4 Hoffmann-La Roche Inc., Nutley, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4 Hoffmann-La Roche Inc., Nutley, NJ;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000961519","display_name":"Alain C. Mita","orcid":"https://orcid.org/0009-0009-3260-4793","observed_orcids":["https://orcid.org/0009-0009-3260-4793","https://orcid.org/0000-0002-5387-0160"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alain Mita","raw_affiliation_strings":["5 Institute for Drug Development - Cancer Therapy and Research Center, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5 Institute for Drug Development - Cancer Therapy and Research Center, San Antonio, TX","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"8","issue":"12_Supplement","first_page":"B123","last_page":"B123"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.009499999694526196,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-like-growth-factor-receptor","display_name":"insulin-like growth factor receptor","score":0.8510000109672546},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.921999990940094},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.9739999771118164},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.796999990940094},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7160000205039978},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9610000252723694},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9869999885559082},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.7110000252723694},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.5320000052452087},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.5789999961853027},{"id":"https://openalex.org/keywords/sarcoma","display_name":"sarcoma","score":0.9020000100135803},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.5910000205039978},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5080000162124634},{"id":"https://openalex.org/keywords/cho-cell-expression","display_name":"CHO cell expression","score":0.38100001215934753},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.4320000112056732}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.769721508026123},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5919448733329773},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.580700159072876},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5516220927238464},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5241632461547852},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4636493921279907},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.4388173818588257},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.42392468452453613},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4232124090194702},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.4209103584289551},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3470922112464905}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-09-b123","doi":"https://doi.org/10.1158/1535-7163.targ-09-b123","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-09-b123","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8299999833106995,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2512096769","https://openalex.org/W2264947172","https://openalex.org/W2532022854","https://openalex.org/W2156136395","https://openalex.org/W2734688671","https://openalex.org/W1976269797","https://openalex.org/W1993624360","https://openalex.org/W1547298604","https://openalex.org/W2155000185","https://openalex.org/W2590559378"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"R1507":[2,39,52,267,411],"is":[3,412,438],"a":[4,42,56,191,272],"fully":[5],"human":[6],"monoclonal":[7],"antibody":[8],"(IgG1)":[9],"which":[10,233],"selectively":[11],"inhibits":[12],"insulin-like":[13],"growth":[14],"factor":[15],"receptor":[16],"(IGF-1R).":[17],"This":[18,385],"phase":[19,75,443],"I":[20],"dose-escalation":[21],"study":[22,181],"in":[23,118,292,375,401,423,442],"patients":[24],"with":[25,177,383,410],"advanced":[26],"malignant":[27],"solid":[28],"tumors":[29],"explored":[30],"the":[31,293,317,343,392,402,415],"safety,":[32],"pharmacokinetics":[33,268],"(PK)":[34],"and":[35,50,90,98,106,190,214,219,224,240,252,264,316,339,348,356,420,434,437],"pharmacodynamics":[36],"(PD)":[37],"of":[38,86,232,303],"manufactured":[40],"using":[41],"Chinese":[43],"hamster":[44],"ovarian":[45],"(CHO)":[46],"cell":[47],"line.":[48],"Materials":[49],"Methods:":[51],"was":[53,188,195,306,321,335,379,387],"administered":[54],"as":[55],"weekly":[57],"(qW)":[58],"or":[59,69,134,208],"every":[60],"3":[61,121,285],"weeks":[62],"(q3W)":[63],"infusion":[64],"until":[65,389],"dose-limiting":[66],"toxicity":[67],"(DLT)":[68],"progressive":[70],"disease":[71,155],"were":[72,79,110,115,204,235,269,363],"observed.":[73],"Standard":[74],"1":[76,172,175,207],"inclusion":[77],"criteria":[78],"used":[80],"including":[81,174],"adequate":[82],"organ":[83],"function,":[84],"lack":[85],"uncontrolled":[87],"intercurrent":[88],"illnesses,":[89],"CD4":[91],"count":[92],">200/\u00b5l.":[93],"Clinical":[94],"assessments":[95,101],"for":[96,182,342],"safety":[97],"DLT,":[99],"tumor":[100],"(every":[102],"6":[103,125],"weeks),":[104],"PK":[105,433],"PD":[107,435],"blood":[108],"sampling":[109],"performed.":[111],"Results:":[112],"36":[113],"pts":[114,152,228,243],"sequentially":[116],"enrolled":[117],"dose":[119,193,297,396,406,430],"levels":[120,378],"mg/kg":[122,126,130,136,286,295,350,394,404,428,450],"(n=":[123,127,131,138],"3),":[124],"13),":[128],"9":[129,246,346,393,427],"7)":[132],"qW":[133,287,347,395,429],"16":[135,294,349,403,449],"q3W":[137,296,351,405,451],"13).":[139],"Median":[140],"pt":[141,176],"age":[142],"52":[143],"yrs":[144],"(range":[145],"18\u201380),":[146],"M:F":[147],"21:15.":[148],"Efficacy:":[149],"12":[150],"(33%)":[151],"showed":[153],"stable":[154,424],"(mean":[156],"duration":[157],"25":[158],"weeks,":[159],"range":[160],"11\u201350":[161],"weeks)":[162],"[prostate":[163],"4,":[164],"sarcoma":[165],"4;":[166],"adrenal,":[167],"appendix,":[168],"soft":[169],"tissue,":[170],"stomach":[171],"each],":[173],"prostate":[178],"cancer":[179],"on":[180],"72+":[183],"weeks.":[184],"Safety:":[185],"No":[186],"DLT":[187,419],"observed":[189,380],"maximum-tolerated":[192],"(MTD)":[194],"not":[196,399],"reached.":[197],"Drug-related":[198],"adverse":[199],"events":[200],"(AEs)":[201],"by":[202],"CTCAE":[203],"mostly":[205],"grade":[206,249],"2:":[209],"fatigue":[210,253],"(11":[211],"pts),":[212],"myalgia":[213],"nausea":[215],"(5":[216],"each),":[217,223,255],"hyperglycemia":[218,251],"muscle":[220],"spasms":[221],"(4":[222],"anorexia":[225],"(3).":[226],"Fourteen":[227],"had":[229,245],"20":[230],"SAEs,":[231],"2":[234],"related":[236],"to":[237,288,365],"R1507:":[238],"dyspnea":[239],"pyrexia.":[241],"Six":[242],"(17%)":[244],"drug-related":[247],"AEs":[248],"\u22653:":[250],"(2":[254],"diabetes":[256],"mellitus,":[257],"performance":[258],"status":[259],"decreased,":[260,262],"weight":[261],"thrombocytopenia,":[263],"dyspnea.":[265],"PK:":[266],"nonlinear.":[270],"After":[271],"single":[273,369],"IV":[274],"infusion,":[275],"mean":[276,318,328],"clearance":[277],"(CL)":[278],"decreased":[279],"from":[280,310],"\u223c1000":[281],"mL/Day":[282,290],"(CV=17.4%)":[283],"at":[284,331,391,414],"580":[289],"(CV=25.7%)":[291],"group,":[298],"suggesting":[299],"saturable":[300],"elimination.":[301],"Volume":[302],"distribution":[304],"(Vd)":[305],"relatively":[307],"small,":[308],"ranging":[309],"5.8":[311],"\u2013":[312],"7.8":[313],"L":[314],"(CV=7.8\u201377%),":[315],"half":[319],"life":[320],"10.5":[322],"days":[323],"(CV=28.2%).":[324],"At":[325],"week":[326],"10,":[327],"trough":[329],"concentration":[330],"steady":[332],"state":[333],"(Css,min)":[334],"40.5,":[336],"97.3,":[337],"127.5,":[338],"90.3":[340],"ug/mL":[341],"3,":[344],"6,":[345],"groups":[352],"respectively.":[353],"Mean":[354],"CL":[355],"Vd":[357],"values":[358],"calculated":[359,367],"after":[360,368,381],"multiple":[361],"administrations":[362],"comparable":[364],"those":[366],"administration.":[370],"PD:":[371],"Dose":[372],"proportional":[373],"increase":[374,386],"total":[376],"IGF-1":[377],"treatment":[382],"R1507.":[384],"sustained":[388,400,432],"redosing":[390],"level":[397],"but":[398],"level.":[407],"Conclusions:":[408],"Treatment":[409],"tolerable":[413],"doses":[416],"tested":[417],"without":[418],"has":[421],"resulted":[422],"disease.":[425],"The":[426],"achieves":[431],"effects":[436],"currently":[439],"being":[440,453],"evaluated":[441],"II":[444],"trials.":[445],"Doses":[446],"higher":[447],"than":[448],"are":[452],"explored.":[454],"Citation":[455],"Information:":[456],"Mol":[457],"Cancer":[458],"Ther":[459],"2009;8(12":[460],"Suppl):B123.":[461]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2016-06-24T00:00:00"}